Preparation & characterization of embelin–phospholipid complex as effective drug delivery tool

Original Article

Abstract

The aim of the present study was to prepare an embelin–phospholipid complex (EPC) formulation in an attempt to enhance the water solubility and to characterize the new developed formulation. Embelin, due to water insolubility causes poor bioavailability by oral route. To improve the bioavailability and prolong its duration in body system, its phospholipid complexes were prepared by a simple and reproducible method. EPC was formulated by mechanical dispersion method using ethanol as a reaction medium, embelin and phospholipids were dissolved into the medium, after that organic solvent was removed under vacuum condition and EPC was formed. The complex formation was confirmed by carrying out FTIR, 1H-NMR, XRD, DSC and microscopical studies. Solubility and in vitro studies were carried out to ascertain the solubility and dissolution pattern of free and complexed embelin. Content of embelin in EPC was found to be 92.44% (w/w). FTIR, 1H NMR, DSC and XRD data confirmed the formation of embelin phospholipid complex. Water solubility of embelin was improved from 3 to 42 μg/mL in the prepared complex. n-Octanol solubility were also altered for free embelin and EPC from 2.3 to 39 μg/mL. Unlike the free embelin, which showed a total of only 19% drug release at the end of 120 min, EPC showed 99.80% release at the end of 120 min of dissolution study in distilled water. Microscopical characterization of the developed formulation also showed the entrapment of embelin in the lipid core showing complex structure, which was further, supported by change in surface morphology of embelin on microscopical examination. Hence, the present findings demonstrate that complexing embelin with phospholipid can be further explored for improved therapeutic implications.

Keywords

Embelin Phospholipid complex Solubility XRD DSC FTIR 

References

  1. 1.
    Padh, H., Patel, B.V.: Herbal drugs. Curr. Sci. 81, 15–16 (2001)Google Scholar
  2. 2.
    Sikarwar, M.S., Sharma, S., Jain, A.K., Parial, S.D.: Preparation, characterization and evaluation of marsupsin–phospholipid complex. AAPS PharmSciTech 9, 129–137 (2008)CrossRefGoogle Scholar
  3. 3.
    Manach, C., Scalbert, A., Morand, C., Rémésy, C., Jiménez, L.: Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79, 727–747 (2004)Google Scholar
  4. 4.
    Bombardelli, E., Curri, S.B., Loggia, R., Della, N., Del, P., Tubaro, A., Gariboldi, P.: Complexes between phospholipids and vegetal derivatives of biological interest. Fitoterapia 60, 1–9 (1989)Google Scholar
  5. 5.
    Citernesi, U., Sciacchitano, M.: Phospholipids/active ingredient complexes. Cosm. Toil. 110, 57–68 (1995)Google Scholar
  6. 6.
    Bhattacharya, S.: Phytosomes: emerging strategy in delivery of herbal drugs and nutraceuticals. Pharma Times 41, 9–12 (2009)Google Scholar
  7. 7.
    Fahy, E., Subramaniam, S., Brown, H.A.: A comprehensive classification system for lipids. J. Lipid Res. 46, 839–861 (2005). doi:10.1194/jlr.E400004-JLR200 Google Scholar
  8. 8.
    Maiti, K., Mukherjee, K., Gantait, A., Saha, B.P., Mukherjee, P.K.: Enhanced therapeutic potential of naringenin-phospholipid complex in rats. J. Pharm. Pharmacol. 58, 1227–1233 (2006)CrossRefGoogle Scholar
  9. 9.
    Naik, S.R., Pilgaonkar, V.W., Panda, V.S.: Evaluation of antioxidant activity of Ginkgo biloba phytosomes in rat brain. Phytotherap. Res. 20, 1013–1016 (2006)CrossRefGoogle Scholar
  10. 10.
    Han, Y.M., Yan, D., Yuan, H.L.: Study on bioavilability of oxymatrine-phospholipid complex in rats. Zhongguo Zhong Yao Za Zhi 32, 2508–2510 (2007)Google Scholar
  11. 11.
    Maiti, K., Mukherjee, K., Gantait, A., Ahamed, H.N., Saha, B.P., Mukherjee, P.K.: Enhanced therapeutic benefit of quercetin–phospholipid complex in carbon tetrachloride–induced acute liver injury in rats: a comparative study. Iranian J. Pharmacol. Ther. 4, 84–90 (2005)Google Scholar
  12. 12.
    Maiti, K., Mukherjee, K., Gantait, A., Saha, B.P., Mukherjee, P.K.: Curcumin–phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm. 330, 155–163 (2007)CrossRefGoogle Scholar
  13. 13.
    Sikarwar, M.S., Sharma, S., Jain, A.K., Parial, S.D.: Preparation, characterization and evaluation of marsupsin–phospholipid complex, AAPS PharmSciTech. 9 (2008). doi:10.1208/s12249-007-9020-x
  14. 14.
    Chopra, R.N., Nayar, S.L., Chopra, I.C.: Glossary of Indian medicinal plants. National Institute of Science Communication, CSIR, New Delhi, India (1999)Google Scholar
  15. 15.
    Chopra, R.N., Chopra, I.C., Varma, B.S.: Supplement to glossary of Indian medicinal plants. Publication and Information Directorate, CSIR, New Delhi, India (1969)Google Scholar
  16. 16.
    Tripathi, S.N.: Screening of hypoglycemic action in certain indigenous drugs. J. Res. Ind. Med. 14, 159–169 (1979)Google Scholar
  17. 17.
    Bhandari, U., Kanojia, R., Pillai, K.K.: Effect of Ethanolic extract of Embelia ribes on dyslipidemia in diabetic rats. Int. J. Exp. Diab. Res. 3, 159–162 (2002)CrossRefGoogle Scholar
  18. 18.
    Krishnaswamy, M., Purushothaman, K.K.: Antifertility properties of Embelia ribes. Ind. J. Exp. Biol. 18, 638–639 (1980)Google Scholar
  19. 19.
    Chitra, M., Devi, C.S., Sukumar, E.: Antibacterial activity of Embelin. Fitoterapia 74, 401–403 (2003)Google Scholar
  20. 20.
    Chander, H., Ahmed, S.M.: Comparative evaluation of fungicidal quinones and natural embelin against some insect pests of storage. J. Stored Prod. Res. 25, 81–91 (1989)CrossRefGoogle Scholar
  21. 21.
    Chitra, M., Sukumar, E., Suja, V., Devi, C.S.: Antitumour, antinflammatory and analgesic property of embelin, a plant product. Chemotherapy 40, 109–113 (1994)CrossRefGoogle Scholar
  22. 22.
    Mori, T., Doi, R., Kida, A., Nagai, K., Kami, K., Ito, D., Toyoda, E., Kawaguchi, Y.: Effect of the XIAP inhibitor embelin on TRAIL-induced pancreatic cancer cells. J. Surg. Res. 142, 281–286 (2007)CrossRefGoogle Scholar
  23. 23.
    Nikolovska-Coleska, Z., Xu, L., Hu, Z., Tomita, Y., Li, P., Roller, P.P.: Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J. Med. Chem. 47, 2430–2440 (2004)CrossRefGoogle Scholar
  24. 24.
    Chena, J., Nikolovska-Coleskaa, Z., Wanga, G., Qiu, S., Wang, S.: Design, synthesis, and characterization of new Embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein. Bioorg. Med. Chem. Lett. 16, 5805–5808 (2006)CrossRefGoogle Scholar
  25. 25.
    Ahn, K.S., Sethi, G., Aggarwal, B.B.: Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products. Mol. Pharmacol. 71, 209–219 (2007)CrossRefGoogle Scholar
  26. 26.
    Ansari, M.N., Bhandari, U.: Effect of an ethanol extract of Embelia ribes fruits on isoproterenol-induced myocardial infarction in albino rats. Pharm. Biol. 46, 928–932 (2008)CrossRefGoogle Scholar
  27. 27.
    Bhandari, U., Ansari, M.N.: Protective effect of aqueous extract of Embelia ribes Burm fruits in middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Ind. J. Pharmacol. 40, 152–157 (2008)CrossRefGoogle Scholar
  28. 28.
    Gupta, S., Kanwar, U.: Biodistribution of embelin a benzoquinone of male antifertility potential. Fitoterapia 62, 419–425 (1991)Google Scholar
  29. 29.
    Mungai, N.N., Makawitiw, D.W., Konji, V.N.: Effect of different doses and routes of administration of embelin on plasma testosterone levels. Phytotherap. Res. 11, 532–534 (1997)CrossRefGoogle Scholar
  30. 30.
    Gupta, O.P., Ali, M.M., Ghatak, B.J.R., Atal, C.K.: Some pharmacological investigations of Embelin and its semisynthetic derivatives. Ind. J. Physiol. Pharmacol. 21, 31–39 (1977)Google Scholar
  31. 31.
    Yanyu, X., Yunmei, S., Zhipeng, C., Oineng, P.: The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int. J. Pharm. 307, 77–82 (2006)CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Department of PharmacologyFaculty of Pharmacy, Hamdard UniversityNew DelhiIndia

Personalised recommendations